350 related articles for article (PubMed ID: 36555433)
1. Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research.
Flessa CM; Nasiri-Ansari N; Kyrou I; Leca BM; Lianou M; Chatzigeorgiou A; Kaltsas G; Kassi E; Randeva HS
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555433
[TBL] [Abstract][Full Text] [Related]
2. Experimental models of non-alcoholic fatty liver disease in rats.
Kucera O; Cervinkova Z
World J Gastroenterol; 2014 Jul; 20(26):8364-76. PubMed ID: 25024595
[TBL] [Abstract][Full Text] [Related]
3. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Soejima Y; Fukusato T
World J Gastroenterol; 2012 May; 18(19):2300-8. PubMed ID: 22654421
[TBL] [Abstract][Full Text] [Related]
4. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.
Alshawsh MA; Alsalahi A; Alshehade SA; Saghir SAM; Ahmeda AF; Al Zarzour RH; Mahmoud AM
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164140
[TBL] [Abstract][Full Text] [Related]
5. Animal Models of Non-alcoholic Fatty Liver Diseases and Its Associated Liver Cancer.
Lau JKC; Zhang X; Yu J
Adv Exp Med Biol; 2018; 1061():139-147. PubMed ID: 29956212
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.
Teufel A; Itzel T; Erhart W; Brosch M; Wang XY; Kim YO; von Schönfels W; Herrmann A; Brückner S; Stickel F; Dufour JF; Chavakis T; Hellerbrand C; Spang R; Maass T; Becker T; Schreiber S; Schafmayer C; Schuppan D; Hampe J
Gastroenterology; 2016 Sep; 151(3):513-525.e0. PubMed ID: 27318147
[TBL] [Abstract][Full Text] [Related]
7. Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances.
Lau JK; Zhang X; Yu J
J Pathol; 2017 Jan; 241(1):36-44. PubMed ID: 27757953
[TBL] [Abstract][Full Text] [Related]
8. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
9. Animal models of NAFLD from a hepatologist's point of view.
Jahn D; Kircher S; Hermanns HM; Geier A
Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):943-953. PubMed ID: 29990551
[TBL] [Abstract][Full Text] [Related]
10. Rodent Models of Nonalcoholic Fatty Liver Disease.
Zhong F; Zhou X; Xu J; Gao L
Digestion; 2020; 101(5):522-535. PubMed ID: 31600750
[TBL] [Abstract][Full Text] [Related]
11. Generation of a Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease.
Asgharpour A; Sanyal AJ
Methods Mol Biol; 2022; 2455():19-30. PubMed ID: 35212982
[TBL] [Abstract][Full Text] [Related]
12. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ
BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145
[TBL] [Abstract][Full Text] [Related]
13. A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.
Okamoto K; Koda M; Okamoto T; Onoyama T; Miyoshi K; Kishina M; Kato J; Tokunaga S; Sugihara TA; Hara Y; Hino K; Murawaki Y
PLoS One; 2016; 11(5):e0154676. PubMed ID: 27135827
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD).
Kanuri G; Bergheim I
Int J Mol Sci; 2013 Jun; 14(6):11963-80. PubMed ID: 23739675
[TBL] [Abstract][Full Text] [Related]
15. Zebrafish facilitate non-alcoholic fatty liver disease research: Tools, models and applications.
Chang C; Li H; Zhang R
Liver Int; 2023 Jul; 43(7):1385-1398. PubMed ID: 37122203
[TBL] [Abstract][Full Text] [Related]
16. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
[TBL] [Abstract][Full Text] [Related]
17. Blocking integrin α
Rai RP; Liu Y; Iyer SS; Liu S; Gupta B; Desai C; Kumar P; Smith T; Singhi AD; Nusrat A; Parkos CA; Monga SP; Czaja MJ; Anania FA; Raeman R
J Hepatol; 2020 Nov; 73(5):1013-1022. PubMed ID: 32540177
[TBL] [Abstract][Full Text] [Related]
18. Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease.
Gwag T; Reddy Mooli RG; Li D; Lee S; Lee EY; Wang S
JHEP Rep; 2021 Feb; 3(1):100193. PubMed ID: 33294831
[TBL] [Abstract][Full Text] [Related]
19. Translational Aspects of Diet and Non-Alcoholic Fatty Liver Disease.
Goossens N; Jornayvaz FR
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28956824
[TBL] [Abstract][Full Text] [Related]
20. Mast Cells Promote Nonalcoholic Fatty Liver Disease Phenotypes and Microvesicular Steatosis in Mice Fed a Western Diet.
Kennedy L; Meadows V; Sybenga A; Demieville J; Chen L; Hargrove L; Ekser B; Dar W; Ceci L; Kundu D; Kyritsi K; Pham L; Zhou T; Glaser S; Meng F; Alpini G; Francis H
Hepatology; 2021 Jul; 74(1):164-182. PubMed ID: 33434322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
